AbbVie Inc. (ABBV) vs Dover Corporation (DOV)
A side-by-side comparison of AbbVie Inc. and Dover Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: ABBV is classified in Healthcare; DOV is classified in Industrials. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
ABBV
AbbVie Inc.
$263.48HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
DOV
Dover Corporation
$203.08IndustrialsDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — ABBV vs DOV
growth of $100 · dividends reinvested · last 14yABBV +1164.7%DOV +498.9%ABBV compounded faster
ABBV DOV
ABBV vs DOV: by the numbers
- •ABBV is the larger company ($465.51B vs $27.35B market cap).
- •DOV trades at the lower trailing earnings multiple (24.86 vs 125.98 P/E), one valuation lens rather than an overall verdict.
- •DOV converts more revenue to profit (13.48% vs 5.79% net margin).
- •ABBV grew revenue faster over the past five years (4.59% vs 2.54% CAGR).
- •ABBV pays the higher dividend yield (2.62% vs 1.01%).
Metrics side by side
Valuation
| Metric | ABBV | DOV |
|---|---|---|
| P/E ratio | 125.98 | 24.86 |
| Forward P/E | N/A | 19.27 |
| P/S ratio | 7.26 | 3.31 |
| P/B ratio | 16.57 | 3.62 |
| PEG ratio | N/A | 2.27 |
| EV / EBITDA | 20.46 | 17.14 |
| FCF yield | 4.58% | 4.21% |
Profitability
| Metric | ABBV | DOV |
|---|---|---|
| Gross margin | 70.68% | 39.58% |
| Operating margin | 27.60% | 16.87% |
| Net margin | 5.79% | 13.48% |
| ROE | 13.23% | 14.73% |
| ROIC | 12.97% | 9.40% |
Dividends
| Metric | ABBV | DOV |
|---|---|---|
| Dividend yield | 2.62% | 1.01% |
| Payout ratio | 284.39% | 26.10% |
Growth (annualized)
| Metric | ABBV | DOV |
|---|---|---|
| Revenue CAGR (5Y) | 4.59% | 2.54% |
| EPS CAGR (5Y) | -2.79% | 10.95% |
| FCF CAGR (5Y) | 3.24% | 2.56% |
| Total return CAGR (5Y) | 21.24% | 6.04% |
Frequently asked
- Which has the lower trailing P/E, ABBV or DOV?
- DOV has the lower trailing P/E: ABBV trades at 125.98 and DOV at 24.86. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or DOV?
- Over the past five years, ABBV grew revenue faster — ABBV at a 4.59% CAGR versus DOV at 2.54%.
- Does ABBV or DOV pay a bigger dividend?
- ABBV yields 2.62% and DOV yields 1.01% based on trailing dividends and the latest price.
- Is ABBV or DOV more profitable?
- DOV runs the higher net margin — ABBV at 5.79% versus DOV at 13.48%.
- How have ABBV and DOV total returns compared?
- Over the past 10 years, ABBV delivered 19.57% and DOV delivered 15.37% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioDover P/E ratioAbbVie dividend yieldDover dividend yieldAbbVie ROEDover ROEAbbVie operating marginDover operating marginAbbVie revenue growthDover revenue growthAbbVie free cash flowDover free cash flow
AbbVie & Dover appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.